chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 62.0
Sex: M
Vaccine: COVID19-2
Symptoms: Rash, Rash erythematous, Rash pruritic, Swelling
Clinical narrative: Red swollen bumps that itch.  They are located  at the waistline  below belly button. The area covered is about 7? x 4?. He felt it about an hour after the vaccination. It has been 2 days, itching isn?t as severe and it is improving
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Blood test normal, Headache, Vomiting
Clinical narrative: The evening around dinner time I vomited and then I started having a horrible headache for a full 7 days. I took TYLENOL and or ADVIL to help the pain and it eased the pain somewhat, but it didn't take it completely away. I called my doctor and at the end of May I saw him, and he did blood work which came back normal. I was given ZOLOFT for anxiety dealing with the headaches.
Age: 0.17
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC13, RV5
Symptoms: Hypopnoea, Lethargy, Pallor, Unresponsive to stimuli
Clinical narrative: 25 minutes of lethargy, paleness, shallow breathing, unresponsive
Age: 62.0
Sex: M
Vaccine: UNK
Symptoms: Herpes zoster, Scab
Clinical narrative: Had some legions (looks like shingles) on back of neck (2 larger ones and 3 smaller ones), eye brow (1 small one) and head (2-3 small ones). At first I thought it was a mosquito bite, but then the  larger ones seemed to develop a scab. All were very itchy, mostly the 2 larger ones. Took a good week to go away, but still see the marks of the 5 on the back of my neck. Others are obscured by hair. I know the Shingrix vaccine is not supposed to cause an outbreak, and that is why I am reporting this so it is documented.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Tachycardia
Clinical narrative: Tachycardia- 150bpm at rest for 36 hours after vaccination. Spontaneously resolved after 48 hours. Slight fever of 100 F. degrees.
Age: 4.0
Sex: F
Vaccine: DTAPIPV
Symptoms: Bordetella test positive, Influenza A virus test positive, Respiratory viral panel
Clinical narrative: Although the child was fully vaccinated, the child tested positive for Bordetella Pertussis by PCR on 10-24-2022
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient came in for first dose of Pfizer for COVID-19 vaccination. She was given the Pfizer monovalent with use-by date of 10/21/2022. Error was discovered during charting after patient had left the clinic. Patient was called to inform them of the situation, as our office had called a Pfizer representative who needs to determine if stability is still acceptable. We informed her that we were waiting for his response, and offered her to wait on his answer or come in for a new vaccination per CDC guidelines. She decided to wait, and a final decision is pending.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Blood test normal, Chest X-ray normal, Chest pain, Condition aggravated
Clinical narrative: The day after I received the vaccine my arm swelled up, I had chest pains. I went to my doctor we thought I may have been having an allergic reaction and anxiety because of that. He advised me to take Benadryl to help. The chest pains kept up and I started wearing a watch that helps to monitor heart rate. In January my heart monitor indicated that heart rate dropped to 72, I went to the emergency room. My anxiety kicked in so by the time I did get seen my heart rate was back to normal. My doctor has put me on a regimen of baby aspirin, it took three months for my chest pains to lessen.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Electrocardiogram normal, Heart rate decreased, Peripheral swelling
Clinical narrative: The day after I received the vaccine my arm swelled up, I had chest pains. I went to my doctor we thought I may have been having an allergic reaction and anxiety because of that. He advised me to take Benadryl to help. The chest pains kept up and I started wearing a watch that helps to monitor heart rate. In January my heart monitor indicated that heart rate dropped to 72, I went to the emergency room. My anxiety kicked in so by the time I did get seen my heart rate was back to normal. My doctor has put me on a regimen of baby aspirin, it took three months for my chest pains to lessen.
Age: 71.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Cough, Nasal congestion, Oropharyngeal pain, Pain in extremity
Clinical narrative: I experienced a breakthrough case of COVID-19 with the following symptoms: stuffy nose, sore arm, sore throat and a severe cough.
Age: 71.0
Sex: F
Vaccine: COVID19-2
Symptoms: SARS-CoV-2 test, Vaccine breakthrough infection
Clinical narrative: I experienced a breakthrough case of COVID-19 with the following symptoms: stuffy nose, sore arm, sore throat and a severe cough.
Age: 41.0
Sex: F
Vaccine: FLUC4
Symptoms: Antinuclear antibody, Full blood count, Hypoaesthesia, Lymphocyte percentage increased, Metabolic function test
Clinical narrative: 10/21/22: The muscles in my left upper arm began to spasm and this continues through 10/25/22. 10/25/22: I experienced numbness and tingling in my left arm, right arm, and left leg.  I was seen in clinic.
Age: 41.0
Sex: F
Vaccine: FLUC4
Symptoms: Muscle spasms, Paraesthesia, Red blood cell sedimentation rate, Rheumatoid factor
Clinical narrative: 10/21/22: The muscles in my left upper arm began to spasm and this continues through 10/25/22. 10/25/22: I experienced numbness and tingling in my left arm, right arm, and left leg.  I was seen in clinic.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Discomfort, Gait disturbance, Injection site inflammation, Injection site warmth
Clinical narrative: Worsening of left knee pain to the point that it was difficult walk, go up and down stairs. Site was inflamed and hot. It's not that I haven't had MILD discomfort in that knee, but it worsened significantly after the booster.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Magnetic resonance imaging, X-ray limb
Clinical narrative: Worsening of left knee pain to the point that it was difficult walk, go up and down stairs. Site was inflamed and hot. It's not that I haven't had MILD discomfort in that knee, but it worsened significantly after the booster.
Age: 81.0
Sex: F
Vaccine: FLU4
Symptoms: Expired product administered
Clinical narrative: The patient was given an expired dose of flu vaccine; which expired on 6/2022.; Patient contacted and explain what had happened and offered another dose of flu shot; she declined at this time;
Age: 34.0
Sex: F
Vaccine: VARZOS
Symptoms: Wrong product administered
Clinical narrative: Given the wrong vaccine due to administrative oversight. Shingles vaccine was administered instead of Chicken pox vaccine. No symptoms so far.
Age: 71.0
Sex: F
Vaccine: COVID19-2
Symptoms: Pyrexia
Clinical narrative: Fever for 10 hours
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Vaccine breakthrough infection
Clinical narrative: I had a breakthrough case of Covid and did a teleconference call where the doctor prescribed PAXLOVID.
Age: 70.0
Sex: M
Vaccine: COVID19-2
Symptoms: Ageusia, COVID-19, Chills, Cough, Fatigue
Clinical narrative: I started feeling I had a sore throat and more congestion and coughing then I'm used to. When I laid down i continued coughing. I had extreme fatigue, headache, chills, chest congestion, lost my taste. My doctor subscribed me Paxlovid. I used cough syrup and Tylenol.
Age: 70.0
Sex: M
Vaccine: COVID19-2
Symptoms: Headache, Oropharyngeal pain, Respiratory tract congestion, SARS-CoV-2 test positive, Upper respiratory tract congestion
Clinical narrative: I started feeling I had a sore throat and more congestion and coughing then I'm used to. When I laid down i continued coughing. I had extreme fatigue, headache, chills, chest congestion, lost my taste. My doctor subscribed me Paxlovid. I used cough syrup and Tylenol.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Dizziness, Dyspnoea, Dysstasia
Clinical narrative: I had an extreme amount of sneezing and runny nose for a few days. I had a cough and dizziness. The worst was the fatigue where I couldn't stand up to take my inhaler. After that I got a secondary sinus infection and was left with long COVID-19 which I still have. I am left with some symptoms up until now like fatigue, low energy primarily. For a while I had heart palpitations and shortness of breath but these have gone now.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Palpitations, Post-acute COVID-19 syndrome, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: I had an extreme amount of sneezing and runny nose for a few days. I had a cough and dizziness. The worst was the fatigue where I couldn't stand up to take my inhaler. After that I got a secondary sinus infection and was left with long COVID-19 which I still have. I am left with some symptoms up until now like fatigue, low energy primarily. For a while I had heart palpitations and shortness of breath but these have gone now.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Sinusitis, Sneezing
Clinical narrative: I had an extreme amount of sneezing and runny nose for a few days. I had a cough and dizziness. The worst was the fatigue where I couldn't stand up to take my inhaler. After that I got a secondary sinus infection and was left with long COVID-19 which I still have. I am left with some symptoms up until now like fatigue, low energy primarily. For a while I had heart palpitations and shortness of breath but these have gone now.
Age: 69.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Unevaluable event
Clinical narrative: patient hospitalized
Age: 85.0
Sex: M
Vaccine: COVID19, COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: Local HD in house to assist with COVID booster clinic for our facility.  First series of Moderna had been administered on 3/2/22. Pt was administered a Bivalent vaccine instead of his required 2nd dose. This error was discussed with LHD and I was advised of: If a bivalent Moderna vaccine is administered for a primary dose: Repeat the dose immediately (no minimum interval) with a monovalent Moderna vaccine because administration of the bivalent Moderna vaccine will result in a lower-than-authorized primary series dosage. Some experts suggest delaying the repeat dose for 8 weeks after the invalid dose. After the dose has been repeated, continue with the recommended vaccination schedule (i.e., complete the primary series with a monovalent Moderna vaccine, then administer a bivalent booster dose at least 2 months after completion of the primary series). A monovalent dose was administered immediately per this recommendation
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Anxiety, Blood test normal, Discomfort, Electrocardiogram abnormal, Head discomfort
Clinical narrative: I started having a really strange headache on one side of my head. I called the doctor, and they told me to check my blood pressure and by the next morning it was back to normal. I developed head pressure and when I went to the doctor, they gave me an EKG and sent me to the hospital because there was a concern about my heart rate. After all the testing, they told me everything was fine. No medication was prescribed. I was going back and forth to the doctor. In February I had a panic attack, I didn't know what I was feeling so I went to the emergency room. They completed the same test and said everything was normal. They advised me to take ibuprofen but did not prescribe anything. I went to my primary doctor who told me I was suffering from anxiety. He also referred me to a cardiologist. I went to the cardiologist who did a stress test and confirmed everything was normal. I went to another doctor who did the same test and confirmed all was normal but he began to treat me for anxiety with the medication fluoxetine. I was good until last Monday when I had another panic attack. I returned to my doctor who repeated the battery of test. The EKG showed slightly elevated on October 24. I now have to have a sonogram next week. I still feel like my body is heavy from side effects.
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Heart rate abnormal, Heart rate increased, Panic attack, Ultrasound scan normal
Clinical narrative: I started having a really strange headache on one side of my head. I called the doctor, and they told me to check my blood pressure and by the next morning it was back to normal. I developed head pressure and when I went to the doctor, they gave me an EKG and sent me to the hospital because there was a concern about my heart rate. After all the testing, they told me everything was fine. No medication was prescribed. I was going back and forth to the doctor. In February I had a panic attack, I didn't know what I was feeling so I went to the emergency room. They completed the same test and said everything was normal. They advised me to take ibuprofen but did not prescribe anything. I went to my primary doctor who told me I was suffering from anxiety. He also referred me to a cardiologist. I went to the cardiologist who did a stress test and confirmed everything was normal. I went to another doctor who did the same test and confirmed all was normal but he began to treat me for anxiety with the medication fluoxetine. I was good until last Monday when I had another panic attack. I returned to my doctor who repeated the battery of test. The EKG showed slightly elevated on October 24. I now have to have a sonogram next week. I still feel like my body is heavy from side effects.
Age: 35.0
Sex: F
Vaccine: COVID19-2
Symptoms: Wrong product administered
Clinical narrative: Patient was given Pfizer Bivalent vaccine for 2nd dose (primary series)
Age: 71.0
Sex: F
Vaccine: FLU4
Symptoms: Hypersensitivity, Nasal congestion, Swelling face
Clinical narrative: pt husband came in stating pt had some reactions after receiving vaccination yesterday. spoke with pt on the phone. pt stated she had some facial swelling mostly on the left side. pt realized around bedtime when her glasses felt tight. pt also reported having extreme stuffy nose, but had no other breathing issue. pt does have diagnosis of Lupus and has informed me sometimes her immune system flares up. pt took benadryl and swelling has gone down and has no other issues at the moment. I have recommended for her to notify her MD to see if they can determine if this was true allergy to vaccination. I have added allergy to pt's profile for the time being unless md can determine it was not caused by the vaccination. pt has no other concerns at this time
Age: 8.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Bronchial wall thickening, COVID-19, Chest X-ray abnormal, Coinfection
Clinical narrative: COVID + 10/24/22 .  Vaccination status - Pfizer x2 BRIEF OVERVIEW: Discharge Provider: MD  Primary Care Physician at Discharge: MD  Admission Date: 10/24/2022  Discharge Date: 10/27/2022   Active Hospital Problems   Diagnosis Date Noted POA ? Influenza A 10/25/2022 Yes ? COVID 10/25/2022 Yes ? Autism 08/16/2016   DETAILS OF HOSPITAL STAY: Dehydration  Viral pneumonia  Hypoxia    HOSPITAL COURSE: Patient is a 9 y.o. male with PMHx autism spectrum disorder and HIE who was admitted on 10/24/2022 for acute hypoxic respiratory failure and moderate dehydration secondary to Covid-19 and Influenza A coinfection.    The patient presented on 10/24/2022 to hospital after 6 days of lethargy, fever, cough, and headache. He was tachypenic and hypoxic on arrival requiring 2L NC. He was also given two NS boluses for dehydration after failing a PO challenge. Film array was positive for both Influenza A and Covid-19. CXR revealed peribronchial thickening consistent with his viral illness. He was admitted to the hospitalist team for further care.    Patient was treated with Tamiflu and Decadron. After consultation with Infectious Disease, Remdesivir was also begun in the setting of Covid-19 positivity and hypoxia. The patient was supported with supplemental oxygen and maintenance IVF.    He was successfully able to be weaned from supplemental oxygen approximately 24hrs prior to discharge.    At the time of discharge, the patient was hemodynamically stable and on room air. His PO intake was increasing. He was discharged with a two day course of Tamiflu to complete a total of 5 days of treatment. All parental questions and concerns were addressed prior to discharge.    CONSULTS/RECOMMENDATIONS: Infectious Disease              - Use Remdesivir for the duration of admission
Age: 8.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Dehydration, Headache, Hypophagia, Hypoxia
Clinical narrative: COVID + 10/24/22 .  Vaccination status - Pfizer x2 BRIEF OVERVIEW: Discharge Provider: MD  Primary Care Physician at Discharge: MD  Admission Date: 10/24/2022  Discharge Date: 10/27/2022   Active Hospital Problems   Diagnosis Date Noted POA ? Influenza A 10/25/2022 Yes ? COVID 10/25/2022 Yes ? Autism 08/16/2016   DETAILS OF HOSPITAL STAY: Dehydration  Viral pneumonia  Hypoxia    HOSPITAL COURSE: Patient is a 9 y.o. male with PMHx autism spectrum disorder and HIE who was admitted on 10/24/2022 for acute hypoxic respiratory failure and moderate dehydration secondary to Covid-19 and Influenza A coinfection.    The patient presented on 10/24/2022 to hospital after 6 days of lethargy, fever, cough, and headache. He was tachypenic and hypoxic on arrival requiring 2L NC. He was also given two NS boluses for dehydration after failing a PO challenge. Film array was positive for both Influenza A and Covid-19. CXR revealed peribronchial thickening consistent with his viral illness. He was admitted to the hospitalist team for further care.    Patient was treated with Tamiflu and Decadron. After consultation with Infectious Disease, Remdesivir was also begun in the setting of Covid-19 positivity and hypoxia. The patient was supported with supplemental oxygen and maintenance IVF.    He was successfully able to be weaned from supplemental oxygen approximately 24hrs prior to discharge.    At the time of discharge, the patient was hemodynamically stable and on room air. His PO intake was increasing. He was discharged with a two day course of Tamiflu to complete a total of 5 days of treatment. All parental questions and concerns were addressed prior to discharge.    CONSULTS/RECOMMENDATIONS: Infectious Disease              - Use Remdesivir for the duration of admission
Age: 8.0
Sex: M
Vaccine: COVID19
Symptoms: Influenza, Influenza A virus test positive, Lethargy, Pneumonia viral, Pyrexia
Clinical narrative: COVID + 10/24/22 .  Vaccination status - Pfizer x2 BRIEF OVERVIEW: Discharge Provider: MD  Primary Care Physician at Discharge: MD  Admission Date: 10/24/2022  Discharge Date: 10/27/2022   Active Hospital Problems   Diagnosis Date Noted POA ? Influenza A 10/25/2022 Yes ? COVID 10/25/2022 Yes ? Autism 08/16/2016   DETAILS OF HOSPITAL STAY: Dehydration  Viral pneumonia  Hypoxia    HOSPITAL COURSE: Patient is a 9 y.o. male with PMHx autism spectrum disorder and HIE who was admitted on 10/24/2022 for acute hypoxic respiratory failure and moderate dehydration secondary to Covid-19 and Influenza A coinfection.    The patient presented on 10/24/2022 to hospital after 6 days of lethargy, fever, cough, and headache. He was tachypenic and hypoxic on arrival requiring 2L NC. He was also given two NS boluses for dehydration after failing a PO challenge. Film array was positive for both Influenza A and Covid-19. CXR revealed peribronchial thickening consistent with his viral illness. He was admitted to the hospitalist team for further care.    Patient was treated with Tamiflu and Decadron. After consultation with Infectious Disease, Remdesivir was also begun in the setting of Covid-19 positivity and hypoxia. The patient was supported with supplemental oxygen and maintenance IVF.    He was successfully able to be weaned from supplemental oxygen approximately 24hrs prior to discharge.    At the time of discharge, the patient was hemodynamically stable and on room air. His PO intake was increasing. He was discharged with a two day course of Tamiflu to complete a total of 5 days of treatment. All parental questions and concerns were addressed prior to discharge.    CONSULTS/RECOMMENDATIONS: Infectious Disease              - Use Remdesivir for the duration of admission
Age: 8.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Tachypnoea
Clinical narrative: COVID + 10/24/22 .  Vaccination status - Pfizer x2 BRIEF OVERVIEW: Discharge Provider: MD  Primary Care Physician at Discharge: MD  Admission Date: 10/24/2022  Discharge Date: 10/27/2022   Active Hospital Problems   Diagnosis Date Noted POA ? Influenza A 10/25/2022 Yes ? COVID 10/25/2022 Yes ? Autism 08/16/2016   DETAILS OF HOSPITAL STAY: Dehydration  Viral pneumonia  Hypoxia    HOSPITAL COURSE: Patient is a 9 y.o. male with PMHx autism spectrum disorder and HIE who was admitted on 10/24/2022 for acute hypoxic respiratory failure and moderate dehydration secondary to Covid-19 and Influenza A coinfection.    The patient presented on 10/24/2022 to hospital after 6 days of lethargy, fever, cough, and headache. He was tachypenic and hypoxic on arrival requiring 2L NC. He was also given two NS boluses for dehydration after failing a PO challenge. Film array was positive for both Influenza A and Covid-19. CXR revealed peribronchial thickening consistent with his viral illness. He was admitted to the hospitalist team for further care.    Patient was treated with Tamiflu and Decadron. After consultation with Infectious Disease, Remdesivir was also begun in the setting of Covid-19 positivity and hypoxia. The patient was supported with supplemental oxygen and maintenance IVF.    He was successfully able to be weaned from supplemental oxygen approximately 24hrs prior to discharge.    At the time of discharge, the patient was hemodynamically stable and on room air. His PO intake was increasing. He was discharged with a two day course of Tamiflu to complete a total of 5 days of treatment. All parental questions and concerns were addressed prior to discharge.    CONSULTS/RECOMMENDATIONS: Infectious Disease              - Use Remdesivir for the duration of admission
Age: 63.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Unevaluable event
Clinical narrative: patient hospitalized
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Acute kidney injury, Agitation, Asthenia, Bacterial infection, Blood creatinine increased
Clinical narrative: Discharge Provider: MD Primary Care Provider at Discharge: DO Admission Date: 10/25/2022 Discharge Date: 10/27/22  HOSPITAL COURSE: Patient is a 78 y.o. male presented to the emergency department on 10/25 with 6 days of progressive weakness and fatigue and new onset altered mental status.  He noted upper respiratory infection signs symptoms at home and do a COVID test which resulted as positive. PCP started him on molnupiravir.  He had a 1 week history of decreased oral intake and poor appetite.  He and his wife were initially managing symptoms at home, however, wife states that he became agitated and confused with possible hallucinations prompting presentation to the emergency department.    September presentation to the emergency department his vitals stable.  Workup obtained to evaluate for etiology of his symptoms, evidence of pneumonia, superimposed bacterial infection, or source of his fatigue.  Complete blood count largely noncontributory.  His CMP noting increased creatinine from his baseline at 2.05 with baseline of 1.5.  COVID-19 test was positive.  Chest x-ray noting possible left lower lobe infiltrate concerning for possible pneumonia.  Suspect this is related to his COVID-19 infection.  CT head noting multiple chronic findings but no acute process that would explain his altered mental status.  Changes in mental status for suspected to be due to delirium versus antiviral medication.  He was admitted for observation to general medicine service due to AKI on chronic kidney disease stage 3.    He received supportive care with initiation of IV fluids on admission.  His mental status improved to baseline.  He was not a candidate for remdesivir or Decadron, and remained on room air.  Over the course of the next 36 hours his creatinine decreased to baseline.  He was had adequate oral intake.  Vitals remained stable.  He was discharged on 10/27 in stable improved condition.  DISCHARGE DIAGNOSES 1. COVID-19 2.  Acute renal failure on CKD stage 3-resolved 3. Acute metabolic encephalopathy-resolved 4. Transaminitis-resolved 5. Vestibular schwannoma status post resection 6. BPH 7. Chronic obstructive pulmonary disease 8. Coronary artery disease status post stenting 9. Hypertension 10. OSA
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Chest X-ray abnormal, Chronic kidney disease, Computerised tomogram head abnormal, Condition aggravated
Clinical narrative: Discharge Provider: MD Primary Care Provider at Discharge: DO Admission Date: 10/25/2022 Discharge Date: 10/27/22  HOSPITAL COURSE: Patient is a 78 y.o. male presented to the emergency department on 10/25 with 6 days of progressive weakness and fatigue and new onset altered mental status.  He noted upper respiratory infection signs symptoms at home and do a COVID test which resulted as positive. PCP started him on molnupiravir.  He had a 1 week history of decreased oral intake and poor appetite.  He and his wife were initially managing symptoms at home, however, wife states that he became agitated and confused with possible hallucinations prompting presentation to the emergency department.    September presentation to the emergency department his vitals stable.  Workup obtained to evaluate for etiology of his symptoms, evidence of pneumonia, superimposed bacterial infection, or source of his fatigue.  Complete blood count largely noncontributory.  His CMP noting increased creatinine from his baseline at 2.05 with baseline of 1.5.  COVID-19 test was positive.  Chest x-ray noting possible left lower lobe infiltrate concerning for possible pneumonia.  Suspect this is related to his COVID-19 infection.  CT head noting multiple chronic findings but no acute process that would explain his altered mental status.  Changes in mental status for suspected to be due to delirium versus antiviral medication.  He was admitted for observation to general medicine service due to AKI on chronic kidney disease stage 3.    He received supportive care with initiation of IV fluids on admission.  His mental status improved to baseline.  He was not a candidate for remdesivir or Decadron, and remained on room air.  Over the course of the next 36 hours his creatinine decreased to baseline.  He was had adequate oral intake.  Vitals remained stable.  He was discharged on 10/27 in stable improved condition.  DISCHARGE DIAGNOSES 1. COVID-19 2.  Acute renal failure on CKD stage 3-resolved 3. Acute metabolic encephalopathy-resolved 4. Transaminitis-resolved 5. Vestibular schwannoma status post resection 6. BPH 7. Chronic obstructive pulmonary disease 8. Coronary artery disease status post stenting 9. Hypertension 10. OSA
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Confusional state, Decreased appetite, Delirium, Fatigue, Full blood count normal
Clinical narrative: Discharge Provider: MD Primary Care Provider at Discharge: DO Admission Date: 10/25/2022 Discharge Date: 10/27/22  HOSPITAL COURSE: Patient is a 78 y.o. male presented to the emergency department on 10/25 with 6 days of progressive weakness and fatigue and new onset altered mental status.  He noted upper respiratory infection signs symptoms at home and do a COVID test which resulted as positive. PCP started him on molnupiravir.  He had a 1 week history of decreased oral intake and poor appetite.  He and his wife were initially managing symptoms at home, however, wife states that he became agitated and confused with possible hallucinations prompting presentation to the emergency department.    September presentation to the emergency department his vitals stable.  Workup obtained to evaluate for etiology of his symptoms, evidence of pneumonia, superimposed bacterial infection, or source of his fatigue.  Complete blood count largely noncontributory.  His CMP noting increased creatinine from his baseline at 2.05 with baseline of 1.5.  COVID-19 test was positive.  Chest x-ray noting possible left lower lobe infiltrate concerning for possible pneumonia.  Suspect this is related to his COVID-19 infection.  CT head noting multiple chronic findings but no acute process that would explain his altered mental status.  Changes in mental status for suspected to be due to delirium versus antiviral medication.  He was admitted for observation to general medicine service due to AKI on chronic kidney disease stage 3.    He received supportive care with initiation of IV fluids on admission.  His mental status improved to baseline.  He was not a candidate for remdesivir or Decadron, and remained on room air.  Over the course of the next 36 hours his creatinine decreased to baseline.  He was had adequate oral intake.  Vitals remained stable.  He was discharged on 10/27 in stable improved condition.  DISCHARGE DIAGNOSES 1. COVID-19 2.  Acute renal failure on CKD stage 3-resolved 3. Acute metabolic encephalopathy-resolved 4. Transaminitis-resolved 5. Vestibular schwannoma status post resection 6. BPH 7. Chronic obstructive pulmonary disease 8. Coronary artery disease status post stenting 9. Hypertension 10. OSA
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Hypertransaminasaemia, Hypophagia, Mental status changes, Metabolic encephalopathy, Metabolic function test abnormal
Clinical narrative: Discharge Provider: MD Primary Care Provider at Discharge: DO Admission Date: 10/25/2022 Discharge Date: 10/27/22  HOSPITAL COURSE: Patient is a 78 y.o. male presented to the emergency department on 10/25 with 6 days of progressive weakness and fatigue and new onset altered mental status.  He noted upper respiratory infection signs symptoms at home and do a COVID test which resulted as positive. PCP started him on molnupiravir.  He had a 1 week history of decreased oral intake and poor appetite.  He and his wife were initially managing symptoms at home, however, wife states that he became agitated and confused with possible hallucinations prompting presentation to the emergency department.    September presentation to the emergency department his vitals stable.  Workup obtained to evaluate for etiology of his symptoms, evidence of pneumonia, superimposed bacterial infection, or source of his fatigue.  Complete blood count largely noncontributory.  His CMP noting increased creatinine from his baseline at 2.05 with baseline of 1.5.  COVID-19 test was positive.  Chest x-ray noting possible left lower lobe infiltrate concerning for possible pneumonia.  Suspect this is related to his COVID-19 infection.  CT head noting multiple chronic findings but no acute process that would explain his altered mental status.  Changes in mental status for suspected to be due to delirium versus antiviral medication.  He was admitted for observation to general medicine service due to AKI on chronic kidney disease stage 3.    He received supportive care with initiation of IV fluids on admission.  His mental status improved to baseline.  He was not a candidate for remdesivir or Decadron, and remained on room air.  Over the course of the next 36 hours his creatinine decreased to baseline.  He was had adequate oral intake.  Vitals remained stable.  He was discharged on 10/27 in stable improved condition.  DISCHARGE DIAGNOSES 1. COVID-19 2.  Acute renal failure on CKD stage 3-resolved 3. Acute metabolic encephalopathy-resolved 4. Transaminitis-resolved 5. Vestibular schwannoma status post resection 6. BPH 7. Chronic obstructive pulmonary disease 8. Coronary artery disease status post stenting 9. Hypertension 10. OSA
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pneumonia, Respiratory symptom, SARS-CoV-2 test positive, Superinfection
Clinical narrative: Discharge Provider: MD Primary Care Provider at Discharge: DO Admission Date: 10/25/2022 Discharge Date: 10/27/22  HOSPITAL COURSE: Patient is a 78 y.o. male presented to the emergency department on 10/25 with 6 days of progressive weakness and fatigue and new onset altered mental status.  He noted upper respiratory infection signs symptoms at home and do a COVID test which resulted as positive. PCP started him on molnupiravir.  He had a 1 week history of decreased oral intake and poor appetite.  He and his wife were initially managing symptoms at home, however, wife states that he became agitated and confused with possible hallucinations prompting presentation to the emergency department.    September presentation to the emergency department his vitals stable.  Workup obtained to evaluate for etiology of his symptoms, evidence of pneumonia, superimposed bacterial infection, or source of his fatigue.  Complete blood count largely noncontributory.  His CMP noting increased creatinine from his baseline at 2.05 with baseline of 1.5.  COVID-19 test was positive.  Chest x-ray noting possible left lower lobe infiltrate concerning for possible pneumonia.  Suspect this is related to his COVID-19 infection.  CT head noting multiple chronic findings but no acute process that would explain his altered mental status.  Changes in mental status for suspected to be due to delirium versus antiviral medication.  He was admitted for observation to general medicine service due to AKI on chronic kidney disease stage 3.    He received supportive care with initiation of IV fluids on admission.  His mental status improved to baseline.  He was not a candidate for remdesivir or Decadron, and remained on room air.  Over the course of the next 36 hours his creatinine decreased to baseline.  He was had adequate oral intake.  Vitals remained stable.  He was discharged on 10/27 in stable improved condition.  DISCHARGE DIAGNOSES 1. COVID-19 2.  Acute renal failure on CKD stage 3-resolved 3. Acute metabolic encephalopathy-resolved 4. Transaminitis-resolved 5. Vestibular schwannoma status post resection 6. BPH 7. Chronic obstructive pulmonary disease 8. Coronary artery disease status post stenting 9. Hypertension 10. OSA
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Confusional state, Cough, Decreased appetite, Delirium, Eye discharge
Clinical narrative: Discharge Provider: MD Primary Care Provider at Discharge: DO Admission Date: 10/25/2022 Discharge Date: 10/27/22  HOSPITAL COURSE: Patient is a 78 y.o. male presented to the emergency department on 10/25 with 6 days of progressive weakness and fatigue and new onset altered mental status.  He noted upper respiratory infection signs symptoms at home and do a COVID test which resulted as positive. PCP started him on molnupiravir.  He had a 1 week history of decreased oral intake and poor appetite.  He and his wife were initially managing symptoms at home, however, wife states that he became agitated and confused with possible hallucinations prompting presentation to the emergency department.    September presentation to the emergency department his vitals stable.  Workup obtained to evaluate for etiology of his symptoms, evidence of pneumonia, superimposed bacterial infection, or source of his fatigue.  Complete blood count largely noncontributory.  His CMP noting increased creatinine from his baseline at 2.05 with baseline of 1.5.  COVID-19 test was positive.  Chest x-ray noting possible left lower lobe infiltrate concerning for possible pneumonia.  Suspect this is related to his COVID-19 infection.  CT head noting multiple chronic findings but no acute process that would explain his altered mental status.  Changes in mental status for suspected to be due to delirium versus antiviral medication.  He was admitted for observation to general medicine service due to AKI on chronic kidney disease stage 3.    He received supportive care with initiation of IV fluids on admission.  His mental status improved to baseline.  He was not a candidate for remdesivir or Decadron, and remained on room air.  Over the course of the next 36 hours his creatinine decreased to baseline.  He was had adequate oral intake.  Vitals remained stable.  He was discharged on 10/27 in stable improved condition.  DISCHARGE DIAGNOSES 1. COVID-19 2.  Acute renal failure on CKD stage 3-resolved 3. Acute metabolic encephalopathy-resolved 4. Transaminitis-resolved 5. Vestibular schwannoma status post resection 6. BPH 7. Chronic obstructive pulmonary disease 8. Coronary artery disease status post stenting 9. Hypertension 10. OSA
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Full blood count, Hypophagia, Malaise, Mental status changes
Clinical narrative: Discharge Provider: MD Primary Care Provider at Discharge: DO Admission Date: 10/25/2022 Discharge Date: 10/27/22  HOSPITAL COURSE: Patient is a 78 y.o. male presented to the emergency department on 10/25 with 6 days of progressive weakness and fatigue and new onset altered mental status.  He noted upper respiratory infection signs symptoms at home and do a COVID test which resulted as positive. PCP started him on molnupiravir.  He had a 1 week history of decreased oral intake and poor appetite.  He and his wife were initially managing symptoms at home, however, wife states that he became agitated and confused with possible hallucinations prompting presentation to the emergency department.    September presentation to the emergency department his vitals stable.  Workup obtained to evaluate for etiology of his symptoms, evidence of pneumonia, superimposed bacterial infection, or source of his fatigue.  Complete blood count largely noncontributory.  His CMP noting increased creatinine from his baseline at 2.05 with baseline of 1.5.  COVID-19 test was positive.  Chest x-ray noting possible left lower lobe infiltrate concerning for possible pneumonia.  Suspect this is related to his COVID-19 infection.  CT head noting multiple chronic findings but no acute process that would explain his altered mental status.  Changes in mental status for suspected to be due to delirium versus antiviral medication.  He was admitted for observation to general medicine service due to AKI on chronic kidney disease stage 3.    He received supportive care with initiation of IV fluids on admission.  His mental status improved to baseline.  He was not a candidate for remdesivir or Decadron, and remained on room air.  Over the course of the next 36 hours his creatinine decreased to baseline.  He was had adequate oral intake.  Vitals remained stable.  He was discharged on 10/27 in stable improved condition.  DISCHARGE DIAGNOSES 1. COVID-19 2.  Acute renal failure on CKD stage 3-resolved 3. Acute metabolic encephalopathy-resolved 4. Transaminitis-resolved 5. Vestibular schwannoma status post resection 6. BPH 7. Chronic obstructive pulmonary disease 8. Coronary artery disease status post stenting 9. Hypertension 10. OSA
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Metabolic function test abnormal, Pneumonia, Pulmonary congestion, Respiratory symptom, Rhinorrhoea
Clinical narrative: Discharge Provider: MD Primary Care Provider at Discharge: DO Admission Date: 10/25/2022 Discharge Date: 10/27/22  HOSPITAL COURSE: Patient is a 78 y.o. male presented to the emergency department on 10/25 with 6 days of progressive weakness and fatigue and new onset altered mental status.  He noted upper respiratory infection signs symptoms at home and do a COVID test which resulted as positive. PCP started him on molnupiravir.  He had a 1 week history of decreased oral intake and poor appetite.  He and his wife were initially managing symptoms at home, however, wife states that he became agitated and confused with possible hallucinations prompting presentation to the emergency department.    September presentation to the emergency department his vitals stable.  Workup obtained to evaluate for etiology of his symptoms, evidence of pneumonia, superimposed bacterial infection, or source of his fatigue.  Complete blood count largely noncontributory.  His CMP noting increased creatinine from his baseline at 2.05 with baseline of 1.5.  COVID-19 test was positive.  Chest x-ray noting possible left lower lobe infiltrate concerning for possible pneumonia.  Suspect this is related to his COVID-19 infection.  CT head noting multiple chronic findings but no acute process that would explain his altered mental status.  Changes in mental status for suspected to be due to delirium versus antiviral medication.  He was admitted for observation to general medicine service due to AKI on chronic kidney disease stage 3.    He received supportive care with initiation of IV fluids on admission.  His mental status improved to baseline.  He was not a candidate for remdesivir or Decadron, and remained on room air.  Over the course of the next 36 hours his creatinine decreased to baseline.  He was had adequate oral intake.  Vitals remained stable.  He was discharged on 10/27 in stable improved condition.  DISCHARGE DIAGNOSES 1. COVID-19 2.  Acute renal failure on CKD stage 3-resolved 3. Acute metabolic encephalopathy-resolved 4. Transaminitis-resolved 5. Vestibular schwannoma status post resection 6. BPH 7. Chronic obstructive pulmonary disease 8. Coronary artery disease status post stenting 9. Hypertension 10. OSA
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 test positive, Superinfection
Clinical narrative: Discharge Provider: MD Primary Care Provider at Discharge: DO Admission Date: 10/25/2022 Discharge Date: 10/27/22  HOSPITAL COURSE: Patient is a 78 y.o. male presented to the emergency department on 10/25 with 6 days of progressive weakness and fatigue and new onset altered mental status.  He noted upper respiratory infection signs symptoms at home and do a COVID test which resulted as positive. PCP started him on molnupiravir.  He had a 1 week history of decreased oral intake and poor appetite.  He and his wife were initially managing symptoms at home, however, wife states that he became agitated and confused with possible hallucinations prompting presentation to the emergency department.    September presentation to the emergency department his vitals stable.  Workup obtained to evaluate for etiology of his symptoms, evidence of pneumonia, superimposed bacterial infection, or source of his fatigue.  Complete blood count largely noncontributory.  His CMP noting increased creatinine from his baseline at 2.05 with baseline of 1.5.  COVID-19 test was positive.  Chest x-ray noting possible left lower lobe infiltrate concerning for possible pneumonia.  Suspect this is related to his COVID-19 infection.  CT head noting multiple chronic findings but no acute process that would explain his altered mental status.  Changes in mental status for suspected to be due to delirium versus antiviral medication.  He was admitted for observation to general medicine service due to AKI on chronic kidney disease stage 3.    He received supportive care with initiation of IV fluids on admission.  His mental status improved to baseline.  He was not a candidate for remdesivir or Decadron, and remained on room air.  Over the course of the next 36 hours his creatinine decreased to baseline.  He was had adequate oral intake.  Vitals remained stable.  He was discharged on 10/27 in stable improved condition.  DISCHARGE DIAGNOSES 1. COVID-19 2.  Acute renal failure on CKD stage 3-resolved 3. Acute metabolic encephalopathy-resolved 4. Transaminitis-resolved 5. Vestibular schwannoma status post resection 6. BPH 7. Chronic obstructive pulmonary disease 8. Coronary artery disease status post stenting 9. Hypertension 10. OSA
Age: 41.0
Sex: F
Vaccine: FLU4
Symptoms: Immediate post-injection reaction, Injection site pain, Neck pain, Paraesthesia
Clinical narrative: Received flu shot this morning (not sure if one I selected above is correct). Immediately I felt my arm become tingly down to fingers when injected. Arm continued to stay tingly until now- 2 hours later. Took Ibprofen 25 min after injection, started icing 45 min after injection. Nurses filled out incident report and told me to report here. Ibprofen is not helping tingly feeling. Normal arm soreness at point of injection. Some soreness/tingle of left side of neck.  Injection was high on left shoulder.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Angiogram pulmonary normal, Asthenia, COVID-19, Condition aggravated, Cough
Clinical narrative: Discharge Provider: MD Primary Care Provider at Discharge: MD  Admission Date: 10/21/2022 Discharge Date: 10/23/2022  PRESENTING PROBLEM: Acute respiratory disease due to COVID-19 virus  COVID-19    HOSPITAL COURSE:    Patient is a 84 y.o. male with a prior medical history of chronic kidney disease stage 3, hypertension, hyperlipidemia, coronary artery disease, BPH, coronary artery disease, PVD, PAD, and basal cell carcinoma the skin who presents to the hospital on 10/21/2000 with cough, shortness of breath and fever.  The patient's wife tested COVID positive about 1 week prior.  The patient began having symptom onset on 10/21/2022 and also tested positive for COVID-19.  He noted shortness of breath that was worse with activity.  Nonproductive cough and postnasal drip A fever of 101.1 at home and generalized weakness.   Upon evaluation in emergency department the patient had a CTA of the chest completed which was negative for pulmonary embolism or pneumonia.  He was found to be hypoxic with ambulation and given a dose of Decadron in the emergency department. The patient was admit for can you had observation and IV Decadron.  The patient has remained off of supplemental oxygen since admission to the hospital.  Will discharge home with an additional 3 doses of Decadron to complete a 5 day course.  He was also given Mucinex for expectorant and Claritin to help with post-nasal drip.  Remdesivir was not initiated IV was not persistently hypoxic during stay. PRN Albuterol inhaler provided significant relief for the patient therefore will continue this upon discharge as well.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Dyspnoea exertional, Exposure to SARS-CoV-2, Hypoxia, Malaise
Clinical narrative: Discharge Provider: MD Primary Care Provider at Discharge: MD  Admission Date: 10/21/2022 Discharge Date: 10/23/2022  PRESENTING PROBLEM: Acute respiratory disease due to COVID-19 virus  COVID-19    HOSPITAL COURSE:    Patient is a 84 y.o. male with a prior medical history of chronic kidney disease stage 3, hypertension, hyperlipidemia, coronary artery disease, BPH, coronary artery disease, PVD, PAD, and basal cell carcinoma the skin who presents to the hospital on 10/21/2000 with cough, shortness of breath and fever.  The patient's wife tested COVID positive about 1 week prior.  The patient began having symptom onset on 10/21/2022 and also tested positive for COVID-19.  He noted shortness of breath that was worse with activity.  Nonproductive cough and postnasal drip A fever of 101.1 at home and generalized weakness.   Upon evaluation in emergency department the patient had a CTA of the chest completed which was negative for pulmonary embolism or pneumonia.  He was found to be hypoxic with ambulation and given a dose of Decadron in the emergency department. The patient was admit for can you had observation and IV Decadron.  The patient has remained off of supplemental oxygen since admission to the hospital.  Will discharge home with an additional 3 doses of Decadron to complete a 5 day course.  He was also given Mucinex for expectorant and Claritin to help with post-nasal drip.  Remdesivir was not initiated IV was not persistently hypoxic during stay. PRN Albuterol inhaler provided significant relief for the patient therefore will continue this upon discharge as well.